Vaccine News and Research

Latest Vaccine News and Research

New study identifies cost-effective way to reduce death due to rabies

Every year in India, 20,000 people are estimated to die from rabies. Most of the victims are children. Nearly all of the deaths occur after victims are bitten by rabid dogs. For years, experts have debated the best strategy to reduce this burden.

12 Jan 2017

Penn Vet researchers identify potential target to fight against Ebola

Viruses and their hosts are in a eternal game of one-upmanship. If a host cell evolves a way to stop a virus from spreading, the virus will look for a new path. And so on and so forth.

12 Jan 2017

S. pneumoniae uses hosts' immune defenses to spread infection, study reveals

The bacteria that cause most cases of pneumonia worldwide secrete a toxin that helps them jump from one body to the next - with help from the hosts' immune defenses. This is the finding of a study led by researchers from NYU Langone Medical Center and published online January 11 in Cell Host & Microbe.

12 Jan 2017

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

The University of Maryland Medical Center is now offering a simple genetic test to patients who receive heart stents to determine whether they have a genetic deficiency that affects how they respond to a common drug to prevent blood clots.

12 Jan 2017

Sudden drop in temperature kickstarts flu and other respiratory tract infections

You can pretty much put a mark in your calendar for when the annual flu epidemic begins. Using 20,000 virus samples and weather statistics, researchers have now discovered more details about how outdoor temperature and flu outbreaks are linked.

11 Jan 2017

Researchers identify sub-population of HIV-1 strains with biological properties to transmit new infections

Upon sexual exposure, the AIDS virus must overcome some mighty barriers to find the right target cell and establish a new infection.

11 Jan 2017

Researcher develops innovative way to turn common surgical masks into virus killers

A University of Alberta engineering researcher has developed a new way to treat common surgical masks so they are capable of trapping and killing airborne viruses.

6 Jan 2017

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognize cancer cells and target them for destruction.

3 Jan 2017

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.

27 Dec 2016

Researchers develop synthetic cardiac stem cells that offer therapeutic benefits

Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell.

26 Dec 2016

New study shows efficacy of Ebola vaccine in offering protection against disease

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to a new study that included researchers from the University of Maryland School of Medicine.

26 Dec 2016

UF researchers play integral role in Ebola vaccine trial

An international group of researchers associated with the World Health Organization has published its final report on the Ebola vaccine trial in Guinea, finding that the vaccine is a safe and effective way to prevent Ebola infection.

26 Dec 2016

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year.

23 Dec 2016

Insights into immune system pathways may be key to developing effective TB vaccine

New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine.

22 Dec 2016

TSRI scientists shed light on how antiviral drug stops influenza infections

A new study led by scientists at The Scripps Research Institute (TSRI) is the first to show exactly how the drug Arbidol stops influenza infections. The research reveals that Arbidol stops the virus from entering host cells by binding within a recessed pocket on the virus.

22 Dec 2016

New research offers valuable insight for developing more effective drugs to treat IBD

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis.

22 Dec 2016

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

Clinical study tests adult stem cell therapy for infants with congenital HLHS

In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine and the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).

21 Dec 2016

Breast cancer patient finds new hope with potentially revolutionary treatment

City of Hope patient Susan Young has had a remarkable response to a potentially revolutionary new treatment, a combination of the p53 cancer vaccine and a drug that blocks a specific cancer-aiding protein.

21 Dec 2016

Vaccine News and Research

Latest Vaccine News and Research

New study identifies cost-effective way to reduce death due to rabies

Penn Vet researchers identify potential target to fight against Ebola

S. pneumoniae uses hosts' immune defenses to spread infection, study reveals

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Sudden drop in temperature kickstarts flu and other respiratory tract infections

Researchers identify sub-population of HIV-1 strains with biological properties to transmit new infections

Researcher develops innovative way to turn common surgical masks into virus killers

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

Researchers develop synthetic cardiac stem cells that offer therapeutic benefits

New study shows efficacy of Ebola vaccine in offering protection against disease

UF researchers play integral role in Ebola vaccine trial

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Insights into immune system pathways may be key to developing effective TB vaccine

TSRI scientists shed light on how antiviral drug stops influenza infections

New research offers valuable insight for developing more effective drugs to treat IBD

Researchers engineer promising live-attenuated RSV vaccine candidate

Clinical study tests adult stem cell therapy for infants with congenital HLHS

Breast cancer patient finds new hope with potentially revolutionary treatment

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in